These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 19627513)

  • 21. Circular RNA sequencing indicates circ-IQGAP2 and circ-ZC3H6 as noninvasive biomarkers of primary Sjögren's syndrome.
    Li F; Liu Z; Zhang B; Jiang S; Wang Q; Du L; Xue H; Zhang Y; Jin M; Zhu X; Brown MA; Wu J; Wang X
    Rheumatology (Oxford); 2020 Sep; 59(9):2603-2615. PubMed ID: 32250392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic diagnosis of Sjögren's syndrome.
    Giusti L; Baldini C; Bazzichi L; Bombardieri S; Lucacchini A
    Expert Rev Proteomics; 2007 Dec; 4(6):757-67. PubMed ID: 18067414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
    Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
    Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystatin S-a candidate biomarker for severity of submandibular gland involvement in Sjögren's syndrome.
    Martini D; Gallo A; Vella S; Sernissi F; Cecchettini A; Luciano N; Polizzi E; Conaldi PG; Mosca M; Baldini C
    Rheumatology (Oxford); 2017 Jun; 56(6):1031-1038. PubMed ID: 28339625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling.
    Williams AE; Choi K; Chan AL; Lee YJ; Reeves WH; Bubb MR; Stewart CM; Cha S
    Arthritis Res Ther; 2016 May; 18(1):95. PubMed ID: 27142093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of candidate genes for Sjögren's syndrome using MRL/lpr mouse model of Sjögren's syndrome and cDNA microarray analysis.
    Azuma T; Takei M; Yoshikawa T; Nagasugi Y; Kato M; Otsuka M; Shiraiwa H; Sugano S; Mitamura K; Sawada S; Masuho Y; Seki N
    Immunol Lett; 2002 May; 81(3):171-6. PubMed ID: 11947921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome analysis: a promising biomarker system with special attention to saliva.
    Zheng X; Chen F; Zhang J; Zhang Q; Lin J
    J Membr Biol; 2014 Nov; 247(11):1129-36. PubMed ID: 25135166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantigen-targeting microRNAs in Sjögren's syndrome.
    Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
    Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of differentially expressed genes in primary Sjögren's syndrome.
    Zhang L; Xu P; Wang X; Zhang Z; Zhao W; Li Z; Yang G; Liu P
    J Cell Biochem; 2019 Oct; 120(10):17368-17377. PubMed ID: 31125139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
    Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
    J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of miRNAs in circulating exosomes derived from patients with persistent atrial fibrillation.
    Mun D; Kim H; Kang JY; Park H; Park H; Lee SH; Yun N; Joung B
    FASEB J; 2019 May; 33(5):5979-5989. PubMed ID: 30753098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation.
    Yoshizawa S; Umezu T; Saitoh Y; Gotoh M; Akahane D; Kobayashi C; Ohyashiki JH; Ohyashiki K
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible etiopathogenic genes of Sjögren's syndrome.
    Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
    Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sjögren's syndrome patients with ectopic germinal centers present with a distinct salivary proteome.
    Delaleu N; Mydel P; Brun JG; Jonsson MV; Alimonti A; Jonsson R
    Rheumatology (Oxford); 2016 Jun; 55(6):1127-37. PubMed ID: 26921905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of miRNA expression profile and biomarkers in Sjogren's syndrome complicated with idiopathic pulmonary fibrosis].
    Zhao S; Zhang H; Mei J; Bi DY
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Sep; 38(3):269-272. PubMed ID: 36062798
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA microarray analysis of labial salivary glands of patients with Sjogren's syndrome.
    Wakamatsu E; Nakamura Y; Matsumoto I; Goto D; Ito S; Tsutsumi A; Sumida T
    Ann Rheum Dis; 2007 Jun; 66(6):844-5. PubMed ID: 17513576
    [No Abstract]   [Full Text] [Related]  

  • 38. Discovery and prevalidation of salivary extracellular microRNA biomarkers panel for the noninvasive detection of benign and malignant parotid gland tumors.
    Matse JH; Yoshizawa J; Wang X; Elashoff D; Bolscher JG; Veerman EC; Bloemena E; Wong DT
    Clin Cancer Res; 2013 Jun; 19(11):3032-8. PubMed ID: 23575476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non-coding RNA expression profile in minor salivary gland of primary Sjögren's syndrome.
    Shi H; Cao N; Pu Y; Xie L; Zheng L; Yu C
    Arthritis Res Ther; 2016 May; 18(1):109. PubMed ID: 27188286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study.
    Streckfus C; Bigler L; Navazesh M; Al-Hashimi I
    Clin Oral Investig; 2001 Jun; 5(2):133-5. PubMed ID: 11480812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.